Low-density lipoprotein reconstituted with fatty acid ethyl esters as a physiological vehicle for ethyl ester delivery to intact cells.
Fatty acid ethyl esters (FAEEs), esterification products of ethanol and fatty acids, have been found selectively in the organs damaged by ethanol abuse, and on that basis have been implicated as contributors to ethanol-induced organ damage. To directly assess the cytotoxic potential of FAEEs with intact cells in a physiological system, solubility must be achieved for these highly nonpolar lipids in aqueous medium. After ethanol ingestion, FAEEs can be found within low-density lipoproteins (LDLs). Therefore, to achieve solubility with FAEEs bound to a naturally occurring lipid carrier, we developed a method for FAEE solubilization and delivery to cells in culture. We synthesized radiolabeled FAEEs and incorporated them into human LDL particles that bind to LDL receptors and deliver FAEEs to intact cells. Ethyl palmitate and ethyl oleate were incorporated into LDLs yielding molar ratios of FAEEs to LDLs of 2,153 +/- 249 and 4,208 +/- 403, respectively. LDL reconstituted with FAEE had the same electrophoretic mobility on agarose gel electrophoresis as native LDL, indicating that the reconstituted LDL (rLDL) was not oxidatively modified. Quantitative analysis of the solubilization of FAEEs in aqueous medium was investigated by adding FAEEs to tissue culture medium either directly or reconstituted in LDL at a concentration of 27 microM. The percentage of FAEE quantitated was 40.0 +/- 2.5% and 89.3 +/- 0.6% for FAEEs added directly and in rLDLs, respectively. After sterile filtration of these two media, the percentage of FAEE that remained was 11.8 +/- 1.3% (direct addition) and 74.9 +/- 1.3% (addition within rLDL), further demonstrating that the LDL particle did solubilize the FAEE.(ABSTRACT TRUNCATED AT 250 WORDS)
Bird
D A
DA
Department of Pathology, Massachusetts General Hospital, Boston 02114, USA.
Szczepiorkowski
Z M
ZM
Trace
V C
VC
Laposata
M
M
D006528:Carcinoma, Hepatocellular; D002460:Cell Line; D000431:Ethanol / Q000493:pharmacokinetics* / Q000633:toxicity; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood*; D008113:Liver Neoplasms; D009829:Oleic Acids / Q000493:pharmacokinetics* / Q000633:toxicity; D010169:Palmitic Acids / Q000493:pharmacokinetics* / Q000633:toxicity; D011973:Receptors, LDL / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
D008077:Lipoproteins, LDL; D009829:Oleic Acids; D010169:Palmitic Acids; D011973:Receptors, LDL; D000431:Ethanol; C007680:ethyl palmitate; C033180:ethyl oleate